Skip to main content
. 2015 Sep 30;71(6):797–802. doi: 10.1093/gerona/glv167

Table 1.

Characteristics of Participants in Quartiles Based on IGF-1 Levels

Variables All Level of IGF-1 (ng/mL) p Value
Q1, ≤82 Q2, 83–100 Q3, 101–119 Q4, ≥120
Age, y 71.8±5.4 74.2±6.1 71.8±5.3 71.0±4.8 70.2±4.5 <.001
Sex, % (women) 52 64 56 48 41 <.001
BMI, kg/m2 23.4±3.1 22.8±3.3 23.4±3.1 23.5±2.9 24.1±2.9 <.001
Chronic diseases,* number 1.0±0.8 0.9±0.8 1.0±0.8 1.0±0.8 1.1±0.8 <.001
Medications used, number 1.9±2.0 2.0±2.1 1.9±2.0 1.8±1.9 1.9±1.9 .018
Education, y 11.4±2.5 10.8±2.5 11.3±2.5 11.5±2.4 11.8±2.6 <.001
Smoking, % (current) 10 8 9 13 11 <.001
Drinking alcohol, % (current) 46 38 45 50 52 <.001
Habit of physical exercise, % (no) 63 67 63 60 61 .029
Sleep duration, h 7.7±1.3 7.8±1.4 7.7±1.2 7.7±1.2 7.8±1.2 .068
GDS, score 2.8±2.6 3.1±2.6 2.7±2.6 2.7±2.6 2.6±2.4 <.001
MMSE, score 26.3±2.7 25.9±2.9 26.3±2.7 26.3±2.7 26.5±2.5 <.001
Gait speed 1.3±0.2 1.2±0.2 1.3±0.2 1.3±0.2 1.3±0.2 <.001

Notes: BMI = body mass index; GDS = Geriatric Depression Scale; IGF-1 = insulin-like growth factor-1; MMSE = Mini Mental State Examination. Data are shown as mean ± SD or %. Variables were compared among IGF-1 levels (Q1–Q4).

*Chronic diseases included hypertension, hyperlipidemia, and diabetes.

HHS Vulnerability Disclosure